Diphtheria
📧 Sign up to get email alerts when something new happens for Diphtheria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-11-10Clinical Trial Update: Safety and Immune Response of Different Pediatric Combination Vaccines. [Phase 3]
Phase 3 clinical trial update reporting safety and immune response of pediatric combination vaccines targeting diphtheria, poliomyelitis, an…
-
CLINICAL_TRIALS trial_result · 2010-10-21Clinical Trial Update: Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX® [Phase 4]
Phase 4 post-licensure study assessing safety and immunogenicity of ADACEL and BOOSTRIX vaccines across multiple centers.
-
CLINICAL_TRIALS research · 2010-08-27Clinical Trial Update: Pilot Study Freeze and Transport Immune Cells
A completed pilot study funded by NIAID evaluating the freezing and transport of immune cells for vaccines, covering diphtheria, hepatitis B…
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9 [Phase 3]
Phase 3 trial update assessing persistence of Tdap vaccine (Boostrix) over 1, 3, 5, and 9 years after initial dose and immunogenicity/safety…
-
CLINICAL_TRIALS trial_result · 2010-08-05Clinical Trial Update: Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine. [Phase 3]
Phase 3 trial evaluating Boostrix vaccine versus Decavac for tetanus and acellular pertussis; completed with results posted in 2010.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-07-22Clinical Trial Update: Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine [Phase 4]
Phase 4 open-label multicenter trial assessing safety of redosing with the ADACEL vaccine. Results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-06-07Clinical Trial Update: An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster [Phase 4]
Phase 4 trial evaluating the immunogenicity and safety of a tetanus, diphtheria and acellular pertussis vaccine booster.
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Retrospective Survey of Safety of Fourth Dose Pentacel® in Children
A completed clinical trial update reporting safety results from a retrospective survey of a fourth dose of Pentacel in children.
-
CLINICAL_TRIALS trial_result · 2010-02-12Clinical Trial Update: Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™ [Phase 3]
Phase 3 study evaluating whether Pneumococcal Conjugate Vaccine (PCV) affects the immunogenicity of Pentacel; results were completed and pos…
-
CLINICAL_TRIALS trial_result · 2010-02-11Clinical Trial Update: Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED) [Phase 3]
Phase 3 trial evaluating concomitant administration of Gardasil with a combined diphtheria, tetanus, pertussis and poliomyelitis vaccine in …
-
CLINICAL_TRIALS trial_result · 2010-01-12Clinical Trial Update: Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™ [Phase 4]
Phase 4 study assessing a fifth dose of DAPTACEL in 4- to 6-year-olds previously immunized with PENTACEL. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2009-09-28Clinical Trial Update: Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL® [Phase 3]
Phase 3 clinical trial evaluating the safety and immunogenicity of a fifth DAPTACEL dose in children 4 to 6 years old who previously complet…
-
CLINICAL_TRIALS trial_result · 2009-08-26Clinical Trial Update: Immunogenicity and Safety of GSK Biologicals' Infanrix/Hib in Children [Phase 3]
Phase 3 trial evaluating the immunogenicity and safety of GlaxoSmithKline's Infanrix/Hib vaccine in children; results were posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-08-10Clinical Trial Update: Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children [Phase 4]
Phase 4 study of a new formulation of the DTPa-HBV-IPV/Hib vaccine as a booster in children aged 18-23 months; results were posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines [Phase 3]
Phase 3 clinical trial update of a pneumococcal vaccine booster in healthy children 11-18 months previously primed with the same vaccines; s…
-
CLINICAL_TRIALS trial_result · 2009-07-17Clinical Trial Update: Post Market Surveillance for Infanrix™
Post-market surveillance study for Infanrix evaluated safety in diphtheria, acellular pertussis, and tetanus; results posted in 2009 after c…
-
CLINICAL_TRIALS trial_result · 2009-07-13Clinical Trial Update: Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025) [Phase 3]
Phase 3 trial evaluating the safety of administering Gardasil concurrently with a combined Diphtheria/Tetanus/Pertussis vaccine and a Mening…
-
CLINICAL_TRIALS trial_result · 2009-07-03Clinical Trial Update: Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease
Clinical trial update on Seroimmunity 2007 and a sub-study of the Swedish population assessing seroprevalence for vaccine-preventable diseas…
-
CLINICAL_TRIALS trial_result · 2009-06-25Clinical Trial Update: Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine [Phase 4]
Phase IV study evaluating interchangeability of a liquid pentavalent combination vaccine for diphtheria, tetanus, pertussis, hepatitis B, an…
-
CLINICAL_TRIALS trial_result · 2009-06-25Clinical Trial Update: Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine [Phase 4]
Phase 4 safety and immunogenicity assessment of a liquid pentavalent DTP-HepB-Hib vaccine completed.
-
CLINICAL_TRIALS trial_result · 2009-06-08Clinical Trial Update: Immunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan [Phase 3]
Phase 3 trial in Taiwan evaluating immunogenicity and safety of a fifth dose of ADACEL (diphtheria-tetanus-pertussis vaccine); study complet…
-
CLINICAL_TRIALS trial_result · 2009-05-06Clinical Trial Update: Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine [Phase 4]
This Phase 4 trial reports on long-term safety, immunogenicity, and lot-to-lot consistency for a liquid pentavalent vaccine covering diphthe…
-
EMA withdrawal · 2008-09-10EMA Withdrawn: Quintanrix (Diphtheria toxoid;tetanus toxoid;inactivated Bordetella pertussis;hepatitis B surface antigen (rDNA);Haemophilus influenzae type b polysaccharide) — GlaxoSmithKline Biologicals S.A.
Quintanrix has been withdrawn from the market by GlaxoSmithKline Biologicals S.A., with the status indicating withdrawal for its diphtheria,…
-
CLINICAL_TRIALS trial_result · 2007-08-09Clinical Trial Update: Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine [Phase 4]
A Phase 4 trial assessing the immunogenicity and safety of a fifth booster dose of the diphtheria-tetanus-pertussis-polio vaccine. The study…
-
CLINICAL_TRIALS trial_result · 2006-12-08Clinical Trial Update: Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants [Phase 2]
Phase 2 trial assessing immune response in infants after primary vaccination with Tritanrix-HepB mixed with three Hib-MenAC vaccine formulat…